vs
Forestar Group Inc.（FOR）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
Forestar Group Inc.的季度营收约是Tarsus Pharmaceuticals, Inc.的1.8倍（$273.0M vs $151.7M），Forestar Group Inc.净利率更高（5.6% vs -5.5%，领先11.2%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs 9.0%），Tarsus Pharmaceuticals, Inc.自由现金流更多（$13.0M vs $-157.1M），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs -9.6%）
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
FOR vs TARS — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $273.0M | $151.7M |
| 净利润 | $15.4M | $-8.4M |
| 毛利率 | 20.1% | — |
| 营业利润率 | 7.6% | -5.3% |
| 净利率 | 5.6% | -5.5% |
| 营收同比 | 9.0% | 128.4% |
| 净利润同比 | -6.7% | 63.8% |
| 每股收益（稀释后） | $0.30 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $273.0M | $151.7M | ||
| Q3 25 | $670.5M | $118.7M | ||
| Q2 25 | $390.5M | $102.7M | ||
| Q1 25 | $351.0M | $78.3M | ||
| Q4 24 | $250.4M | $66.4M | ||
| Q3 24 | $551.3M | $48.1M | ||
| Q2 24 | $318.4M | $40.8M | ||
| Q1 24 | $333.8M | $27.6M |
| Q4 25 | $15.4M | $-8.4M | ||
| Q3 25 | $86.9M | $-12.6M | ||
| Q2 25 | $32.9M | $-20.3M | ||
| Q1 25 | $31.6M | $-25.1M | ||
| Q4 24 | $16.5M | $-23.1M | ||
| Q3 24 | $81.5M | $-23.4M | ||
| Q2 24 | $38.7M | $-33.3M | ||
| Q1 24 | $45.0M | $-35.7M |
| Q4 25 | 20.1% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 22.6% | — | ||
| Q4 24 | 22.0% | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 22.5% | — | ||
| Q1 24 | 24.9% | — |
| Q4 25 | 7.6% | -5.3% | ||
| Q3 25 | 16.9% | -12.2% | ||
| Q2 25 | 11.2% | -21.6% | ||
| Q1 25 | 11.6% | -33.5% | ||
| Q4 24 | 8.7% | -36.8% | ||
| Q3 24 | 19.7% | -52.3% | ||
| Q2 24 | 16.2% | -81.6% | ||
| Q1 24 | 17.6% | -136.5% |
| Q4 25 | 5.6% | -5.5% | ||
| Q3 25 | 13.0% | -10.6% | ||
| Q2 25 | 8.4% | -19.8% | ||
| Q1 25 | 9.0% | -32.1% | ||
| Q4 24 | 6.6% | -34.8% | ||
| Q3 24 | 14.8% | -48.7% | ||
| Q2 24 | 12.2% | -81.6% | ||
| Q1 24 | 13.5% | -129.4% |
| Q4 25 | $0.30 | $-0.17 | ||
| Q3 25 | $1.70 | $-0.30 | ||
| Q2 25 | $0.65 | $-0.48 | ||
| Q1 25 | $0.62 | $-0.64 | ||
| Q4 24 | $0.32 | $-0.57 | ||
| Q3 24 | $1.59 | $-0.61 | ||
| Q2 24 | $0.76 | $-0.88 | ||
| Q1 24 | $0.89 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $211.7M | $417.3M |
| 总债务越低越好 | $793.2M | $72.4M |
| 股东权益账面价值 | $1.8B | $343.4M |
| 总资产 | $3.2B | $562.2M |
| 负债/权益比越低杠杆越低 | 0.44× | 0.21× |
8季度趋势，按日历期对齐
| Q4 25 | $211.7M | $417.3M | ||
| Q3 25 | $379.2M | $401.8M | ||
| Q2 25 | $189.2M | $381.1M | ||
| Q1 25 | $174.3M | $407.9M | ||
| Q4 24 | $132.0M | $291.4M | ||
| Q3 24 | $481.2M | $317.0M | ||
| Q2 24 | $359.2M | $323.6M | ||
| Q1 24 | $416.2M | $298.5M |
| Q4 25 | $793.2M | $72.4M | ||
| Q3 25 | $802.7M | $72.3M | ||
| Q2 25 | $872.8M | $72.1M | ||
| Q1 25 | $872.5M | $72.0M | ||
| Q4 24 | $806.8M | $71.8M | ||
| Q3 24 | $706.4M | $71.7M | ||
| Q2 24 | $706.1M | $71.6M | ||
| Q1 24 | $705.7M | $29.9M |
| Q4 25 | $1.8B | $343.4M | ||
| Q3 25 | $1.8B | $335.1M | ||
| Q2 25 | $1.7B | $332.6M | ||
| Q1 25 | $1.6B | $342.5M | ||
| Q4 24 | $1.6B | $224.5M | ||
| Q3 24 | $1.6B | $237.5M | ||
| Q2 24 | $1.5B | $252.2M | ||
| Q1 24 | $1.5B | $275.2M |
| Q4 25 | $3.2B | $562.2M | ||
| Q3 25 | $3.1B | $534.6M | ||
| Q2 25 | $3.1B | $495.0M | ||
| Q1 25 | $3.0B | $500.8M | ||
| Q4 24 | $3.0B | $377.0M | ||
| Q3 24 | $2.8B | $376.3M | ||
| Q2 24 | $2.7B | $376.8M | ||
| Q1 24 | $2.6B | $349.3M |
| Q4 25 | 0.44× | 0.21× | ||
| Q3 25 | 0.45× | 0.22× | ||
| Q2 25 | 0.52× | 0.22× | ||
| Q1 25 | 0.53× | 0.21× | ||
| Q4 24 | 0.50× | 0.32× | ||
| Q3 24 | 0.44× | 0.30× | ||
| Q2 24 | 0.47× | 0.28× | ||
| Q1 24 | 0.48× | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-157.0M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $-157.1M | $13.0M |
| 自由现金流率自由现金流/营收 | -57.5% | 8.6% |
| 资本支出强度资本支出/营收 | 0.0% | 4.2% |
| 现金转化率经营现金流/净利润 | -10.19× | — |
| 过去12个月自由现金流最近4个季度 | $93.0M | $-22.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-157.0M | $19.3M | ||
| Q3 25 | $256.3M | $18.3M | ||
| Q2 25 | $15.8M | $-29.4M | ||
| Q1 25 | $-19.8M | $-20.7M | ||
| Q4 24 | $-450.0M | $-22.2M | ||
| Q3 24 | $119.2M | $-8.7M | ||
| Q2 24 | $-61.7M | $-14.4M | ||
| Q1 24 | $-59.2M | $-37.8M |
| Q4 25 | $-157.1M | $13.0M | ||
| Q3 25 | $255.6M | $16.3M | ||
| Q2 25 | $15.0M | $-30.4M | ||
| Q1 25 | $-20.5M | $-21.2M | ||
| Q4 24 | — | $-22.3M | ||
| Q3 24 | $118.4M | $-8.9M | ||
| Q2 24 | $-62.3M | $-15.4M | ||
| Q1 24 | $-59.8M | $-38.0M |
| Q4 25 | -57.5% | 8.6% | ||
| Q3 25 | 38.1% | 13.8% | ||
| Q2 25 | 3.8% | -29.6% | ||
| Q1 25 | -5.8% | -27.1% | ||
| Q4 24 | — | -33.5% | ||
| Q3 24 | 21.5% | -18.6% | ||
| Q2 24 | -19.6% | -37.8% | ||
| Q1 24 | -17.9% | -137.5% |
| Q4 25 | 0.0% | 4.2% | ||
| Q3 25 | 0.1% | 1.6% | ||
| Q2 25 | 0.2% | 1.0% | ||
| Q1 25 | 0.2% | 0.8% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.1% | 0.6% | ||
| Q2 24 | 0.2% | 2.5% | ||
| Q1 24 | 0.2% | 0.6% |
| Q4 25 | -10.19× | — | ||
| Q3 25 | 2.95× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | -0.63× | — | ||
| Q4 24 | -27.27× | — | ||
| Q3 24 | 1.46× | — | ||
| Q2 24 | -1.59× | — | ||
| Q1 24 | -1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
TARS
暂无分部数据
